Liraglutide 3.0 mg in obese patients: a real life experience

Trial Profile

Liraglutide 3.0 mg in obese patients: a real life experience

Completed
Phase of Trial: Phase IV

Latest Information Update: 10 Jul 2017

At a glance

  • Drugs Liraglutide (Primary)
  • Indications Obesity
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Jul 2017 New trial record
    • 13 Jun 2017 Results (n= 51)presented at the 77th Annual Scientific Sessions of the American Diabetes Association.
    • 20 May 2017 Results presented at the 24th European Congress on Obesity
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top